Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CAC


Fundamental

Company: Camden National Corp
Sector: Financial
Industry: Banks - Regional
Country: USA
Exchange: NASD
Index: RUT
P/E: 12.95
EPS (ttm): 3.14
Insider Own: 3.19%
Shs Outstand: 16.89M
Perf Week: 5.57%
Market Cap: 688.26M
Forward P/E: 8.01
EPS next Y: 5.08
Insider Trans: -0.07%
Shs Float: 16.36M
Perf Month: 2.49%
Enterprise Value: -
PEG: -
EPS next Q: 1.11
Inst Own: 72.21%
Short Float: 3.18%
Perf Quarter: -1.76%
Income: 47.06M
P/S: 2.20
EPS this Y: 22.40%
Inst Trans: 7.01%
Short Ratio: 7.39
Perf Half Y: -4.93%
Sales: 313.08M
P/B: 1.07
EPS next Y Percentage: 13.77%
ROA: 0.74%
Short Interest: 0.52M
Perf YTD: -4.73%
Book/sh: 37.91
P/C: -
EPS next 5Y: -
ROE: 8.24%
52W High: 50.07 -18.67%
Perf Year: 30.05%
Cash/sh: -
P/FCF: 18.73
EPS past 3/5Y: -7.65% -0.40%
ROIC: 6.50%
52W Low: 31.44 29.52%
Perf 3Y: -9.75%
Dividend Est.: 1.68 (4.13%)
EV/EBITDA: -
Sales past 3/5Y: 13.99% 7.04%
Gross Margin: -
Volatility W: 3.11%
Volatility M: 2.15%
Perf 5Y: 21.62%
Dividend TTM: 1.68 (4.13%)
EV/Sales: -
EPS Y/Y TTM: 4.86%
Oper. Margin: 20.44%
ATR (14): 0.96
Perf 10Y: 58.24%
Dividend Ex-Date: Jul 15, 2025
Quick Ratio: -
Sales Y/Y TTM: 18.13%
Profit Margin: 15.03%
RSI (14): 58.69
Recom: 2.75
Dividend Gr. 3/5Y: 4.32% 6.43%
Current Ratio: 0.06
EPS Q/Q: -52.28%
SMA20: 3.36%
Beta: 0.64
Target Price: 48.25
Payout: 46.39%
Debt/Eq: 1.02
Sales Q/Q: 27.38%
SMA50: 3.03%
Rel Volume: 1.71
Prev Close: 40.51
Employees: 586
LT Debt/Eq: 0.13
Earnings: May 06 BMO
SMA200: -2.92%
Avg Volume: 70.28K
Price: 40.72
IPO: Oct 07, 1997
Option/Short: Yes / Yes
EPS/Sales Surpr.: -3.55% 3.94%
Trades:
Volume: 120,355
Change: 0.52%

Technical:


Latest News:

IDEAYA, Gilead To Evaluate Efficacy, Safety Of IDE397+Trodelvy Combination, Stock Up In ... somewhat bullish
IDYA GILD

Summary: IDEAYA Biosciences announced a clinical study collaboration and supply agreement with Gilead Sciences to evaluate IDE397 in combination with Trodelvy in NSCLC, updates expected in 2025, actively enrolling patients in various trials. Stock price is up by 3.78% in pre-market hours.

Full article
2025-02-13T12:00:29Z
Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu Efficacy in ... very bullish
BMY

Summary: Bristol Myers Squibb announced positive results from the Phase 3b/4 PSORIATYK SCALP trial for Sotyktu in treating moderate-to-severe scalp psoriasis.

Full article
2024-09-30T14:18:36Z
New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent ... somewhat bullish
BMY

Summary: New data from the Phase 3 DAYBREAK trial shows sustained decreased brain volume loss in patients treated with Zeposia for up to 5 years, along with declining rates of treatment-emergent adverse events over more than 8 years

Full article
2024-09-18T11:10:09Z
Nike Air Force 1 07 Light British Tan / Cacao Wow - Oct 2024 - KicksOnFire.com neutral
NKE

Summary: Nike releases Air Force 1 '07 Light British Tan / Cacao Wow with premium leather upper and natural tones for a timeless appeal.

Full article
2024-09-18T10:00:53Z
Nike Dunk Low “Bright Cactus” Officially Unveiled - HotNewHipHop somewhat bullish
NKE

Summary: Nike Dunk Low is set to release a new 'Bright Cactus' colorway featuring a white base with vibrant yellow accents, expected to attract attention from sneaker enthusiasts.

Full article
2024-07-06T16:07:32Z
Rob Lowe Net Worth 2024 (FORBES) - CAclubindia neutral
META GOOGL UAL TSLA WMT NFLX MSFT

Summary: Rob Lowe, the American actor, has a net worth of $120 million USD in 2024. His earnings come from acting, with significant salaries per episode in various TV shows. Despite his success, he has faced losses amounting to over $10 million due to a fraud related to purchasing an island.

Full article
2024-07-01T03:29:44Z
“Dusty Cactus” Contrast Brightens A Nocturnal Nike Vapormax Flyknit 2023 - Sneaker News neutral
NKE

Summary: Nike Vapormax Flyknit 2023 'Dusty Cactus' set for Fall '24 launch with a retail price of $210.

Full article
2024-06-30T22:02:26Z
Kansas Sues Pfizer Over Covid-19 Vaccine's Safety, Efficacy - Bloomberg Law News somewhat bearish
PFE

Summary: Kansas sued Pfizer Inc. for allegedly misrepresenting the safety of its Covid-19 vaccine and violating the state’s consumer protection law.

Full article
2024-06-17T20:50:58Z
Austrian Advocacy Group Hits Google With Privacy Complaint Over Chrome Browser somewhat bearish
GOOGL

Summary: Google is facing a complaint from the Austrian group NOYB for allegedly tracking Chrome users, while making efforts to phase out third-party cookies amidst user data privacy concerns.

Full article
2024-06-17T12:19:08Z
North American Morning Briefing: Slow Start to Week as Investors Await Fed Speakers, More ... somewhat bullish
CAC.PA ADBE ADSK AVGO

Summary: Global markets opened on a calm note with modest moves in stock futures. Central-bank decisions and Fed speakers are expected to bring excitement later in the week. Interest-rate decisions in the U.K., Switzerland, Norway, and Australia, along with Fed commentary, are in focus.

Full article
2024-06-17T10:43:03Z
Legrand Products to Power Cisco Live! Network Operation Center - Morningstar neutral
CAC40

Summary: Legrand, a specialist in electrical and digital building infrastructures, announces its support of the Cisco Live Event in Las Vegas by providing products like cabinets, PDUs, fiber solutions, and cable management systems.

Full article
2024-05-29T17:00:12Z
Cactus Plant Flea Market x Nike Air Force 1 Low "White" review - Revolt TV neutral
NKE

Summary: Cactus Plant Flea Market (CPFM) collaborates with Nike on a quirky new release of Air Force 1 sneakers featuring puff-printed phrases and unique details.

Full article
2024-05-20T21:14:28Z